Treatment of epilepsy in adults: Expert opinion in South Korea
- 9 March 2020
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 105, 106942
- https://doi.org/10.1016/j.yebeh.2020.106942
Abstract
No abstract availableKeywords
Funding Information
- Korea Epilepsy Society (2019001)
This publication has 26 references indexed in Scilit:
- Seizure Treatment in Transplant PatientsCurrent Treatment Options in Neurology, 2012
- Treatment of epilepsy in adults: Expert opinion in ChinaEpilepsy & Behavior, 2012
- Prevalence of Treated Epilepsy in Korea Based on National Health Insurance DataJournal of Korean Medical Science, 2012
- Estimation of the burden of active and life‐time epilepsy: A meta‐analytic approachEpilepsia, 2010
- Rational polytherapyEpilepsia, 2009
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Combination Therapy in EpilepsyDrugs, 2006
- Treatment of epilepsy in adults: expert opinion, 2005Epilepsy & Behavior, 2005
- The Expert Consensus Guideline Series: Treatment of EpilepsyEpilepsy & Behavior, 2001